These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. Peeler JS; Niederkorn JY J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767 [TBL] [Abstract][Full Text] [Related]
3. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. Cher DJ; Mosmann TR J Immunol; 1987 Jun; 138(11):3688-94. PubMed ID: 2953788 [TBL] [Abstract][Full Text] [Related]
4. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Joo CK; Pepose JS; Stuart PM Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633 [TBL] [Abstract][Full Text] [Related]
5. In vivo mechanisms of alloreactivity. II. Allospecificity of cytotoxic T lymphocytes in sponge matrix allografts as determined by limiting dilution analysis. Orosz CG; Zinn NE; Sirinek LP; Ferguson RM Transplantation; 1986 Jan; 41(1):84-92. PubMed ID: 2934879 [TBL] [Abstract][Full Text] [Related]
6. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses. Miller SD; Butler LD J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929 [TBL] [Abstract][Full Text] [Related]
7. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity. Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778 [TBL] [Abstract][Full Text] [Related]
8. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers. Suda T; Fujiwara H; Mizushima Y; Shearer GM; Hamaoka T J Natl Cancer Inst; 1986 Dec; 77(6):1267-72. PubMed ID: 2948049 [TBL] [Abstract][Full Text] [Related]
9. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens. Williams IR; Perry LL J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920 [TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of delayed type hypersensitivity reactions specific for Leishmania major antigens to normal mice using murine T cell populations and clones generated in vitro. Lima GC; Engers HD; Louis JA Clin Exp Immunol; 1984 Jul; 57(1):130-8. PubMed ID: 6204797 [TBL] [Abstract][Full Text] [Related]
11. Induction of CTL responses to alloantigens by a Db-specific T helper clone. Kwong PC; Kilburn DG; Teh HS J Immunol; 1984 Aug; 133(2):653-9. PubMed ID: 6203972 [TBL] [Abstract][Full Text] [Related]
12. Is the delayed-type hypersensitivity observed after a low dose of antigen mediated by helper T cells? Milon G; Marchal G; Seman M; Truffa-Bachi P; Zilberfarb V J Immunol; 1983 Mar; 130(3):1103-7. PubMed ID: 6218199 [TBL] [Abstract][Full Text] [Related]
13. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition. Sano Y; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658 [TBL] [Abstract][Full Text] [Related]
14. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. Niederkorn JY; Streilein JW J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396 [TBL] [Abstract][Full Text] [Related]
15. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants. Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773 [TBL] [Abstract][Full Text] [Related]
16. In vivo priming of helper and suppressor T cells by alloantigens. Frequency analysis with the use of an in vitro limiting dilution assay. Bianchi AT; Schilham MW; Benner R; Young P; Lefkovits I J Immunol; 1987 Oct; 139(8):2524-9. PubMed ID: 2958552 [TBL] [Abstract][Full Text] [Related]
17. In vivo mechanisms of alloreactivity. I. Frequency of donor-reactive cytotoxic T lymphocytes in sponge matrix allografts. Orosz CG; Zinn NE; Sirinek L; Ferguson RM Transplantation; 1986 Jan; 41(1):75-83. PubMed ID: 2934878 [TBL] [Abstract][Full Text] [Related]
18. Primary T-cell responses to minor alloantigens. II. Analysis of accessory cell requirements for the development of cytotoxic T lymphocytes. Czitrom AA; Liddell M Immunology; 1983 Dec; 50(4):555-63. PubMed ID: 6228514 [TBL] [Abstract][Full Text] [Related]
19. The role of cytotoxic T lymphocytes in corneal allograft rejection. Hegde S; Niederkorn JY Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223 [TBL] [Abstract][Full Text] [Related]
20. Dependency of the trans vivo delayed type hypersensitivity response on the action of regulatory T cells: implications for monitoring transplant tolerance. Warnecke G; Chapman SJ; Bushell A; Hernandez-Fuentes M; Wood KJ Transplantation; 2007 Aug; 84(3):392-9. PubMed ID: 17700166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]